| 7/20/2021 |
Novotech Joins Decentralized Trials & Research Alliance (DTRA) to Democratize and Accelerate Clinical Trials |
stocksnewsfeed.com |
... The “Decentralized Trials & Research Alliance (DTRA) “ ( https://www.dtra.org/ ) , which was launched in December, 2020, is uniting industry stakeholders, including healthcare companies, regulators, patient groups and research organizations with a singular mission to make clinical trial participation widely accessible by advancing policies, research practices and new technologies in decentralized clinical research.“We are excited to join the DTRA and help accelerate the development of virtual trials in the Asia-Pacific ... |
| 7/9/2021 |
Clinical Trial Enrollment Fairly Robust in Pediatric Neuroblastoma |
Physicians Weekly |
Getting patients enrolled in clinical trials in general continues to be a challenge , but there is good news in the area of pediatric oncology: Researchers reported a high prevalence of population-wide clinical trial participation among North American children with intermediate- or high-risk neuroblastoma. In an analysis of enrollment in the International Neuroblastoma Risk Group ( INRG ) Data Commons, 43.9% (n=3,986/9,087) of patients with neuroblastoma were enrolled in upfront ... |
| 6/17/2021 |
Children's Oncology Group and Signify Health Collaborate to Broaden In-Home Administration for AALL1731 Study |
appliedclinicaltrialsonline.com |
... Trials Online. All rights reserved. © 2021 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved. The Children’s Oncology Group (COG) and Signify Health, Inc. have announced a partnership to facilitate clinical trial participation for pediatric patients through in-home clinical services. Through this new collaboration, pediatric patients participating in COG Study AALL1731, a clinical trial for a therapy to treat B-cell acute lymphoblastic leukemia (B ... |
| 6/15/2021 |
Childbearing vs. clinical trial participation: is it one or the other? |
biomedcentral.com |
Commentary - Open Access - Published: Childbearing vs. clinical trial participation: is it one or the other? Journal 260 (2021) 64 Accesses 1 Altmetric Metrics details Abstract Recent advances have shed light on the importance of early therapeutic intervention for neurodegenerative diseases. Primary prevention trials present a potential disease-modifying strategy for pre-symptomatic patients of autosomal dominant neurodegenerative diseases (ADND), such as early onset familial Alzheimer’s disease (AD) and Huntington ... |
| 6/11/2021 |
ICYMI‚àó00239-7/abstract) |
npjournal.org |
... women on average have lower body and organ weight and a higher percentage of body fat compared with men, which all determine pharmacodynamics of drugs. In an effort to reduce fears or misconceptions about clinical trial participation and increase willingness to enroll, the US Food and Drug Administration has prepared consumer-focused fact sheets for clinicians. The documents are available in English and Spanish and can be accessed at https ... |
| 6/10/2021 |
LAZAREX CANCER FOUNDATION'S 'DISRUPTING THE SYSTEM' SUMMIT |
Globe Newswire |
... More information on the panels, speakers and to register to attend for free: https://www.eventbrite.com/e/disrupting-the-system-iv-tickets-153673177611Panelists and speakers will take on the issues of cancer health disparities, clinical trial participation , patient access and improving cancer health outcomes. They will also explore solutions to fixing these deep-rooted problems.Issues include: Building Trust in Healthcare - exploring successes and solutions including a community-based program ... |
| 6/10/2021 |
LAZAREX CANCER FOUNDATION’S ‘DISRUPTING THE SYSTEM’ SUMMIT TACKLES CANCER HEALTH DISPARITIES MANY WON’T TALK ABOUT |
caymanmama.com |
... More information on the panels, speakers and to register to attend for free: https://www.eventbrite.com/e/disrupting-the-system-iv-tickets-153673177611Panelists and speakers will take on the issues of cancer health disparities, clinical trial participation , patient access and improving cancer health outcomes. They will also explore solutions to fixing these deep-rooted problems.Issues include: Building Trust in Healthcare – exploring successes and solutions including a community-based ... |
| 5/21/2021 |
How Penn Medicine's cancer center boosted Black patients' clinical trial participation |
Becker's Hospital Review |
How Penn Medicine's cancer center boosted Black patients' clinical trial participation Erica Carbajal - Print EmailA community outreach engagement program at Penn Medicine's Abramson Cancer Center in Philadelphia increased the percentage of Black patients in clinical trials from 12 to 24 percent, the health system said May 19.The five-year effort, which began in 2014, reached more than 10,000 people. It involved culturally tailored marketing strategies, partnerships with faith ... |
| 5/21/2021 |
A Hidden Opportunity — Medicaid's Role in Supporting Equitable Access to Clinical Trials | NEJM |
nejm.org |
... package passed by Congress in December 2020 lies a little-known but powerful provision intended to promote equitable access to clinical trials. Beginning in January 2022, coverage of the “routine costs” associated with clinical trial participation will be guaranteed for all Medicaid beneficiaries for the first time in the program’s history. The absence of federal policy in this area until now has most likely suppressed the representation of ... |
| 5/5/2021 |
ASCO-ACCC Piloting Test Tools to Diversify Cancer Clinical Trials |
onclive.com |
... training program, both of which are designed to address one of the barriers to clinical trials participation: trials not routinely offered by clinicians to eligible patients.In a continuation of their collaboration to increase clinical trial participation among patients from underrepresented racial and ethnic groups, the American Society of Clinical Oncology (ASCO) and Association of Community Cancer Centers (ACCC) today announced plans to test a research site assessment tool and ... |
| 5/4/2021 |
AACR 2021: Lack of Trust & Psychological Impact of Cancer Affect African Americans’ Clinical Trial Participation |
Physicians Weekly |
AACR 2021: Lack of Trust & Psychological Impact of Cancer Affect African Americans’ Clinical Trial ParticipationMay 4, 2021“Improving clinical trial participation among African Americans is fundamental to reduce cancer health disparities knowing that their participation will significantly increase the state of knowledge regarding cancer treatment and survivability and ensure that African Americans can benefit from the newest therapies,” write the authors of a qualitative study that included ... |
| 5/4/2021 |
NYC's Black-Owned Barbershops Push for Covid-19 Research |
blackstarnews.com |
... population has experienced 10 percent more COVID-19 cases, nearly 300 percent more hospitalizations, and 90 percent more deaths ( CDC, March 2021 ) than non-Hispanic whites. Historically, the Black community has had the lowest clinical trial participation rates of any racial group and only 8 percent participation in clinical trials of drugs that were approved last year ( FDA, 2020 ).“Historical events like Tuskegee have understandably left many feeling that clinical ... |
| 5/3/2021 |
Engaging Underserved Populations – Improving Diversity and Inclusion |
pharmavoice.com |
Engaging Underserved Populations – Improving Diversity and Inclusion Posted By: Dan Limbach May 3, 2021With health equity at the forefront of many conversations today, study sponsors are seeking ways to make clinical trial participation more inclusive. To help facilitate participation of underserved populations, we have outlined strategic guidance that study sponsors can leverage in their efforts.Learn more ... |
| 5/3/2021 |
Occult Brain Mets Detected in Patients With Advanced Renal Cancer |
healthday.com |
... Network .Ritesh R. Kotecha, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues retrospectively reviewed data from patients with mRCC incidentally diagnosed with asymptomatic brain metastases during screening for clinical trial participation . The analysis included data for 1,689 patients with mRCC from 68 clinical trials conducted between 2001 and 2019 with a median 14.1-month follow-up.The researchers found that 4.3 percent of patients ... |
| 5/3/2021 |
ASCO-ACCC Piloting Test Tools to Diversify Cancer Clinical Trials |
asco.org |
... Clinical Trials Oncology practices and research sites invited to test site assessment tool and implicit bias training program in next phase of collaboration. May 3, 2021In a continuation of their collaboration to increase clinical trial participation among patients from underrepresented racial and ethnic groups, the Oncology (ASCO) and Association of Community Cancer Centers (ACCC) today announced plans to test a research site assessment tool and implicit bias training program ... |
| 5/3/2021 |
Occult Brain Mets Detected in Patients With Advanced Renal Cancer |
thedoctorspost.com |
... Network .Ritesh R. Kotecha, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues retrospectively reviewed data from patients with mRCC incidentally diagnosed with asymptomatic brain metastases during screening for clinical trial participation . The analysis included data for 1,689 patients with mRCC from 68 clinical trials conducted between 2001 and 2019 with a median 14.1-month follow-up.The researchers found that 4.3 percent of patients ... |
| 5/3/2021 |
Occult Brain Mets Detected in Patients With Advanced Renal Cancer |
doctorslounge.com |
... Network .Ritesh R. Kotecha, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues retrospectively reviewed data from patients with mRCC incidentally diagnosed with asymptomatic brain metastases during screening for clinical trial participation . The analysis included data for 1,689 patients with mRCC from 68 clinical trials conducted between 2001 and 2019 with a median 14.1-month follow-up.The researchers found that 4.3 percent of patients ... |
| 4/30/2021 |
Study Finds People of Color More Likely to Participate in Cancer Clinical Trials |
acrpnet.org |
... related data from U.S. adults. Survey years selected included the question, “Did you participate in a clinical trial as part of your cancer treatment?”The analysis of 20,053 respondents revealed an average overall clinical trial participation rate of 6.51%. Among 17,600 white respondents, participation was 6.24%; among 445 Hispanic respondents, participation was 11%; and among 943 Black respondents, participation was 8.27%.“This study informs our understanding of who is ... |
| 4/29/2021 |
Pfizer TV ad aims for clinical trial diversity, with a special invite to the Black community |
FiercePharma |
... Pfizer's latest TV ad encourages people who have been underrepresented in healthcare to consider participating in its clinical trials. (Pfizer) Pfizer newest ad campaign tackles Black community health inequities—with an eye toward increasing clinical trial participation .“For too long, the Black community's health concerns have been ignored, under-resourced, underappreciated, undervalued,” a new TV commercial begins.The narrator points out that the pandemic has highlighted deep racial and ... |
| 4/29/2021 |
Young people of color with a higher income more likely to participate in cancer clinical trials |
news-medical.net |
... health-related data from U.S. adults. Survey years selected included the question, "Did you participate in a clinical trial as part of your cancer treatment?" The analysis of 20,053 respondents revealed an average overall clinical trial participation rate of 6.51%. Among 17,600 white respondents, participation was 6.24%; among 445 Hispanic respondents, participation was 11%; and among 943 Black respondents, participation was 8.27%.This study informs our understanding of who is ... |